|Original language||English (US)|
|Number of pages||2|
|Journal||Clinical Lung Cancer|
|State||Published - Nov 2007|
ASJC Scopus subject areas
- Cancer Research
- Pulmonary and Respiratory Medicine
Shivakumar, L., Lee, D., Ranganathan, A., Gandara, D. R., Herbst, R. S., Langer, C. J., & Lara, P. N. (2007). Phase III trial of gefitinib versus docetaxel in patients with previously treated advanced non-small-cell lung cancer. Clinical Lung Cancer, 8(9), 527-528.